BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15473892)

  • 21. Atrial natriuretic hormone, vessel dilator, long acting natriuretic hormone, and kaliuretic hormone decrease circulating prolactin concentrations.
    Vesely DL; San Miguel GI; Hassan I; Schocken DD
    Horm Metab Res; 2002 May; 34(5):245-9. PubMed ID: 12063637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four cardiac hormones cause death of human cancer cells but not of healthy cells.
    Skelton WP; Pi GE; Vesely DL
    Anticancer Res; 2011 Feb; 31(2):395-402. PubMed ID: 21378317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor's activation of Ras is inhibited by four cardiac hormones.
    Sun Y; Eichelbaum EJ; Lenz A; Wang H; Vesely DL
    Eur J Clin Invest; 2010 May; 40(5):408-13. PubMed ID: 20353436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial natriuretic peptide and long-acting natriuretic peptide inhibit ras in human prostate cancer cells.
    Sun Y; Eichelbaum EJ; Lenz A; Skelton WP; Wang H; Vesely DL
    Anticancer Res; 2009 Jun; 29(6):1889-93. PubMed ID: 19528444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary malignant tumors of the heart: four cardiovascular hormones decrease the number and DNA synthesis of human angiosarcoma cells.
    Vesely BA; Alli A; Song S; Sanchez-Ramos J; Fitz SR; Gower WR; Vesely DL
    Cardiology; 2006; 105(4):226-33. PubMed ID: 16534199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four peptides decrease the number of human pancreatic adenocarcinoma cells.
    Vesely BA; McAfee Q; Gower WR; Vesely DL
    Eur J Clin Invest; 2003 Nov; 33(11):998-1005. PubMed ID: 14636304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure.
    Vesely DL; Perez-Lamboy GI; Schocken DD
    J Card Fail; 2001 Mar; 7(1):55-63. PubMed ID: 11264551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New anticancer agents: hormones made within the heart.
    Vesely DL
    Anticancer Res; 2012 Jul; 32(7):2515-21. PubMed ID: 22753708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells.
    Sun Y; Eichelbaum EJ; Wang H; Vesely DL
    Anticancer Res; 2006; 26(6B):4143-8. PubMed ID: 17201125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac and renal hormones: anticancer effects in vitro and in vivo.
    Vesely DL
    J Investig Med; 2009 Jan; 57(1):22-8. PubMed ID: 19092678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac hormones are c-Jun-N-terminal kinase 2-inhibiting peptides.
    Lane ML; Santana O; Frost CD; Nguyen J; Guerrero J; Skelton WP; Skelton M; Vesely DL
    Anticancer Res; 2012 Mar; 32(3):721-5. PubMed ID: 22399583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers.
    Vesely BA; Eichelbaum EJ; Alli AA; Sun Y; Gower WR; Vesely DL
    Eur J Clin Invest; 2006 Nov; 36(11):810-9. PubMed ID: 17032349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via cyclic GMP.
    Gower WR; Vesely BA; Alli AA; Vesely DL
    Int J Gastrointest Cancer; 2005; 36(2):77-87. PubMed ID: 16648657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac natriuretic peptides: hormones with anticancer effects that localize to nucleus, cytoplasm, endothelium, and fibroblasts of human cancers.
    Saba SR; Vesely DL
    Histol Histopathol; 2006 Jul; 21(7):775-83. PubMed ID: 16598676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac hormones target nuclear oncogenes c-Fos and c-Jun in carcinoma cells.
    Manimala NJ; Frost CD; Lane ML; Higuera M; Beg R; Vesely DL
    Eur J Clin Invest; 2013 Nov; 43(11):1156-62. PubMed ID: 23992401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor.
    Nguyen JP; Frost CD; Lane ML; Skelton WP; Skelton M; Vesely DL
    Eur J Clin Invest; 2012 Oct; 42(10):1061-7. PubMed ID: 22703300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice.
    Hosotani R; Miyamoto Y; Fujimoto K; Doi R; Otaka A; Fujii N; Imamura M
    Clin Cancer Res; 2002 Apr; 8(4):1271-6. PubMed ID: 11948142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial natriuretic peptide prohormone gene expression: hormones and diseases that upregulate its expression.
    Vesely DL
    IUBMB Life; 2002 Mar; 53(3):153-9. PubMed ID: 12102171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four cardiac hormones eliminate 4-fold more human glioblastoma cells than the green mamba snake peptide.
    Vesely BA; Eichelbaum EJ; Alli AA; Sun Y; Gower WR; Vesely DL
    Cancer Lett; 2007 Aug; 254(1):94-101. PubMed ID: 17399891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
    Tanaka S; Pero SC; Taguchi K; Shimada M; Mori M; Krag DN; Arii S
    J Natl Cancer Inst; 2006 Apr; 98(7):491-8. PubMed ID: 16595785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.